Recombinant fibroblast growth factor analogs
US7186526B2 · kind B2 · utility
5Cited by
7References
19Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jun 13, 2005 |
| Grant date | Mar 6, 2007 |
| Priority date | — |
| Expiry date | Jun 13, 2025 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N2830/55
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The DNA sequences encoding analogs of human acidic and basic fibroblast growth factors (FGF) can be recombinantly expressed to obtain practical amounts of proteins useful in effecting both pathologies related to persistent angiogenesis and wound healing and related tissue repair.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.